Skip to main content

Table 1 General characteristics of study participants at baseline study

From: The effects of combined magnesium and zinc supplementation on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease

 

Placebo group

(n = 28)

Magnesium plus zinc group

(n = 27)

Pa

Age (y)

62.6 Âħ 10.8

61.7 Âħ 9.4

0.74

Height (cm)

159.5 Âħ 10.9

162.1 Âħ 7.8

0.32

Weight at study baseline (kg)

76.9 Âħ 12.6

81.3 Âħ 11.7

0.19

Weight at end-of-trial (kg)

77.0 Âħ 12.5

80.9 Âħ 11.4

0.23

Weight change (kg)

0.1 Âħ 1.2

−0.4 Âħ 1.0

0.12

BMI at study baseline (kg/m2)

30.2 Âħ 3.7

30.9 Âħ 3.8

0.47

BMI at end-of-trial (kg/m2)

30.2 Âħ 3.8

30.8 Âħ 3.7

0.59

BMI change (kg/m2)

0.03 Âħ 0.5

−0.1 Âħ 0.4

0.10

  1. Data are meansÂħ SDs
  2. aObtained from independent t-test
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X